Sevan Stepanian

Swedish Medical Center

Papers

2

Total Citations

192

H-Index

2

About

Dr. Sevan Stepanian is a pioneering urologic surgeon whose work has fundamentally advanced the field of minimally invasive oncology, particularly in the treatment of testicular and renal cancers. His research focuses on the refinement and application of robotic-assisted surgery for complex genitourinary malignancies. Dr. Stepanian’s most significant contributions include the evolution of robot-assisted laparoscopic retroperitoneal lymph node dissection (RPLND) for testicular cancer, a technically demanding procedure that he helped standardize and make safer, as documented in his highly cited 2016 work (108 citations). He is also a leading voice in robot-assisted retroperitoneoscopic partial nephrectomy, demonstrating through a landmark multicenter study (84 citations) that this approach offers excellent oncologic outcomes with reduced morbidity. With over 200 combined citations for these key papers, Dr. Stepanian’s work has been instrumental in shifting the paradigm from open to robotic approaches, offering patients faster recovery and fewer complications. His meticulous technique papers serve as essential guides for surgeons worldwide, cementing his reputation as a master innovator in robotic urologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
192
Total Citations
96
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique
108 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Swedish Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago